Target intelligence / Profile preview

Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase (PgaB)

Target
PgaB
Molecular classification
Enzyme, Periplasmic protein
01

Overview

Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase (PgaB) is a periplasmic bacterial enzyme classified in the carbohydrate esterase family 4 (CE4)[1][3]. It participates in biofilm formation by catalyzing the partial de-N-acetylation of the exopolysaccharide PNAG, a modification required for strong intercellular adhesion and biofilm integrity in Escherichia coli and other Gram-negative bacteria[1][3][8]. Structurally, PgaB contains an N-terminal de-N-acetylase domain and a C-terminal domain involved in polymer binding and/or export, sometimes facilitated by interaction with other biofilm machinery proteins, such as PgaA[2]. The enzyme’s specificity and efficiency are governed by a unique active site and metal (Ni2+, Fe3+) coordination, and its function impacts bacterial survival and pathogenicity[1][2][3][8]. Targeting PgaB or its activity is of therapeutic interest in the context of anti-biofilm strategies for combating chronic bacterial infections[2].

Other names
Poly-β-1,6-N-acetyl-D-glucosamine N-deacetylasePNAG N-deacetylasePgaB (gene/protein name)
02

Biological functions

Biofilm formationExopolysaccharide modificationPolymer processing
03

Disease associations

InfectionOther (potential relevance in persistent microbial pathogenesis)
04

Safety considerations

Therapeutic challenge: Modulating this enzyme could theoretically disrupt biofilm formation in pathogenic bacteria, but no clinical safety concerns are established since it is not a human protein

Beyond the preview

Go deeper on Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase (PgaB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase (PgaB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call